Skip to content

Intervention trial of corn silk aqueous extract in patients with glucose metabolism disorder based on non-targeted metabolomics

Intervention trial of corn silk aqueous extract in patients with glucose metabolism disorder based on non-targeted metabolomics

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100047204
Enrollment
Unknown
Registered
2021-06-10
Start date
2021-06-01
Completion date
Unknown
Last updated
2022-01-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes mellitus type 2

Interventions

Experimental group:Take 4.8g CSAE per day (about 60g dry corn silk)

Sponsors

Qiqihaer Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Meet the standards of "Guidelines for Prevention and Treatment of Type 2 Diabetes in China (2017 Edition)", with typical symptoms of diabetes, plus random blood glucose test >= 11.1 mmol/L; or plus fasting blood glucose (FPG) >= 7.0 mmol/L; or plus glucose two h post-load blood glucose >= 11.1 mmol/L; 2. Newly diagnosed patients, without any medication, fasting blood glucose (FPG) <= 9 mmol/L, two h postprandial blood glucose (PBG) <= 14 mmol/L, HbA1c <= 9% ; 3. Aged 18 to 75 years, male or female, BMI 19-35 kg/Square meter; 4. Patients who have good compliance, agree to the treatment of this program, and sign an informed consent.

Exclusion criteria

Exclusion criteria: 1.Patients with acute diabetes in the past month, such as ketoacidosis, hyperosmolar coma; 2.Patients with severe heart, brain, kidney, lung and other vital organ organic diseases; combined with blood Patients with systemic diseases and neurological disorders; 3.Patients with other chronic complications such as diabetic nephropathy, peripheral neuropathy, lower extremity ulcers; 4.Patients with acute or chronic infectious diseases; 5.Patients with digestive system diseases, with use within three months Those who have been treated with antibiotics, hormones, immunosuppressants, and microecological preparations; 6.Pregnant and lactating women, and those with severe allergies; 7.Those who have been treated with other traditional Chinese medicine simultaneously, which affects the judgment of curative effect.

Design outcomes

Primary

MeasureTime frame
Blood sugar;

Countries

China

Contacts

Public ContactCheng Yu

Qiqiher Medical University

qy-chengyu@126.com+86 13946271826

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026